• Explore /
  • Poster
  • / A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.

A phase I study of the safety and activation of a cathepsin-activatable fluorescent cancer-specific probe LUM015.

Abstract Poster

Authors

null

Melodi Javid Whitley

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC

Melodi Javid Whitley , Diana M. Cardona , Dan G. Blazer III, Shelley E. Hwang , Paul J. Mosca , Joan Cahill , Jorge M. Ferrer , David B. Strasfeld , Jeffrey K. Mito , Kyle C. Cuneo , Nicole Larrier , Nerissa Williams , Ivan Spasojevic , Richard F. Riedel , William Eward , W. David Lee , Linda G. Griffith , Moungi Bawendi , David G. Kirsch , Brian E. Brigman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Tumor Biology

Track

Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Clinical Trial Registration Number

NCT01626066

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS11135)

DOI

10.1200/jco.2014.32.15_suppl.tps11135

Abstract #

TPS11135

Poster Bd #

415B

Abstract Disclosures

Similar Posters

First Author: Floris Jan Voskuil

Poster

2023 ASCO Breakthrough

Clinical outcomes of soft tissue sarcoma in the Philippines: A single-center experience.

Clinical outcomes of soft tissue sarcoma in the Philippines: A single-center experience.

First Author: Omar Paningbatan Maaño

First Author: José Antonio Gonzalez

First Author: Nataliya Volodymyrivna Uboha